In one of the first such studies involving human patients with schizophrenia, researchers have provided evidence that deficits in a brain chemical may be responsible for some of the debilitating cognitive deficits -- poor attention, memory and problem-solving abilities -- that accompany the delusions and hallucinations that are the hallmarks of the disorder.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
- Americans find doing their own taxes simpler than improving diet and health
- Tinnitus Severity Is Reduced with Reduction of Depressive Mood – a Prospective Population Study in Sweden
- Deep Brain Stimulation of Nucleus Accumbens Region in Alcoholism Affects Reward Processing
- The Role of Attention in Ambiguous Reversals of Structure-From-Motion